Items Tagged ‘reovirus’

May 14th, 2015

Reolysin® Receives FDA Designation for Gastric Cancer


The U.S. Food and Drug Administration (FDA) has granted an Orphan Drug Designation (ODD) to Reolysin®, an injectable cancer-killing virus, for the treatment of gastric cancer. Oncolytics Biotech® Inc. recently announced the designation in a press release. The FDA grants ODDs in order to advance the evaluation and development of products that demonstrate promise for […]

View full entry

Tags: cancer killing virus, Gastric Cancer, injectable, News, Reolysin, reovirus, Stages I-II Gastric Cancer, Stages III-IV Gastric Cancer